These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9763349)

  • 41. Laboratory markers in the diagnosis of venous thromboembolism.
    Caprini JA; Glase CJ; Anderson CB; Hathaway K
    Circulation; 2004 Mar; 109(12 Suppl 1):I4-8. PubMed ID: 15051662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should surgical patients be screened for thrombophilia?
    Wheeler HB
    Semin Thromb Hemost; 1998; 24 Suppl 1():63-5. PubMed ID: 9840694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
    Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
    Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombophilia testing in patients with venous thrombosis.
    Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inherited thrombophilia and arterial diseases].
    Robert-Ebadi H; Boehlen F; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):331-2, 334-5. PubMed ID: 17370730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing for genetic predisposition to venous thrombosis.
    Marques MB
    MLO Med Lab Obs; 2002 Jan; 34(1):8-13; quiz 20-1. PubMed ID: 11828956
    [No Abstract]   [Full Text] [Related]  

  • 48. Testing for thrombophilia: an evidence-based approach.
    Merriman L; Greaves M
    Postgrad Med J; 2006 Nov; 82(973):699-704. PubMed ID: 17099087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Screening for thrombophilia].
    Lammers T; Schambeck CM
    Hamostaseologie; 2008; 28(3):135-40. PubMed ID: 18521491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory diagnosis of thrombophilic states: where do we stand?
    Tripodi A
    Pathophysiol Haemost Thromb; 2002; 32(5-6):245-8. PubMed ID: 13679650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of thrombophilia: who to screen?
    Baglin T
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):401-4. PubMed ID: 15692251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Who and how to test for hypercoagulability.
    Sandrick K
    CAP Today; 1999 Nov; 13(11):1, 12-4, 16 passim. PubMed ID: 10724677
    [No Abstract]   [Full Text] [Related]  

  • 53. To screen or not to screen: commentary and review on screening laboratory tests in elite athletes.
    Trojian TH
    Curr Sports Med Rep; 2014; 13(4):209-11. PubMed ID: 25014385
    [No Abstract]   [Full Text] [Related]  

  • 54. Effective screening of pathology tests controls costs: thrombophilia testing.
    O'connor N; Carter-Johnson R
    J Clin Pathol; 2006 May; 59(5):556. PubMed ID: 16644892
    [No Abstract]   [Full Text] [Related]  

  • 55. [Thrombophilia: which tests in 2012?].
    de Moerloose P; Casini A; Boehlen F
    Rev Med Interne; 2012 Jun; 33 Suppl 1():S35-9. PubMed ID: 22503240
    [No Abstract]   [Full Text] [Related]  

  • 56. [Accessibility of special clinical laboratory tests in Hungary].
    Kappelmayer J; Antal C; Bereczky Z
    Orv Hetil; 2011 Dec; 152(51):2056-62. PubMed ID: 22130203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Assessment effectiveness of hematological laboratory usage in ambulance of family medicine in Zenica].
    Sivić S; Tandir S; Huseinagić S; Zunić L
    Med Arh; 2007; 61(4):215-7. PubMed ID: 18297993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The quest for the Holy Grail of tissue factor pathway inhibitor deficiency has just begun.
    Ariëns RA
    J Thromb Haemost; 2005 Apr; 3(4):649-50. PubMed ID: 15842348
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic Non-cirrhotic Portal Vein Thrombosis with Cavernous Transformation Secondary to Protein C and S Deficiency.
    Majid Z; Tahir F; Bin Arif T; Ahmed J
    Cureus; 2020 Feb; 12(2):e7142. PubMed ID: 32257687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thrombophilias and stroke: diagnosis, treatment, and prognosis.
    Fields MC; Levine SR
    J Thromb Thrombolysis; 2005 Oct; 20(2):113-26. PubMed ID: 16205860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.